Aprimus Diagnostics Inc., a pioneer in medical device technology, is transforming traditional point-of-care (PoC) diagnostics with its new disposable smart meter device and proprietary quantitative lateral flow assay (qLFA) test used for diagnosing critical disease biomarkers. Their flagship product, the D-dimer test, is designed to rapidly identify and quantify the coagulation status of patients with deep vein thrombosis (DVT) and pulmonary embolism (PE) within minutes at a significant savings compared to similar laboratory test results.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Delray Beach, Fl 33445, Us
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://www.aprimusdx.com
- HQ
- Delray Beach, FL
Aprimus Diagnostics Inc. Questions
Aprimus Diagnostics Inc.'s website is https://www.aprimusdx.com
Aprimus Diagnostics Inc.'s LinkedIn profile is https://www.linkedin.com/company/aprimusdx
Aprimus Diagnostics Inc. has
3 employees.
View email and phone details for 3
employees at Aprimus Diagnostics Inc..
Aprimus Diagnostics Inc.'s industry is
Medical and Diagnostic Laboratories
Aprimus Diagnostics Inc.'s top competitors are
Insilico Medicine,
Zermatt Capital Advisors,
Montage Partners,
Lanzajet,
Gold Ventures Investment,
Centersquare Investment Management,
Endue,
555 Capital Advisors, Llc,
Cb Capital Partners.
Aprimus Diagnostics Inc.'s categories are Medical and Diagnostic Laboratories
Aprimus Diagnostics Inc.'s founding year is 2022
